Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Sept 2026 for Dyne Therapeutics, Inc., €568.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Kerr Douglas: trading record in brief
Kerr Douglas appears in our data through filings on Dyne Therapeutics, Inc. shares, published by SEC (Form 4). We count 3 filings; the first trade dates from 13 August 2026 and the latest from 8 September 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 8 September 2026, reports a transaction of €568 in Dyne Therapeutics, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Kerr Douglas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
35 shares@ US$18.8857Common StockSEC144:0001972481-26-000279
5,000 shares@ US$24.3490.0026% mcap32.9% of flowCommon StockSEC144:0001972481-26-000278
2,443 shares@ US$26.28040.0013% mcap31.2% of flowCommon StockSEC144:0001972481-26-000258
3 of 3 declarations
